Trinity Biotech News
News
0
Ticker
TRIB
ISIN
US8964385046
Trinity Biotech Eulerpool News
Trinity Biotech Stock News
Trinity Biotech is being monitored by journalists and investors worldwide. We gather the latest Trinity Biotech news here.
- December 24·Benzinga
- December 23·Benzinga
- December 10·Yahoo
- December 8·Yahoo
- December 4·Yahoo
- December 1·Yahoo
- November 4·Yahoo
- November 3·Yahoo
- September 10·Yahoo
- September 8·Yahoo
- August 26·Yahoo
- August 20·Yahoo
- August 14·Benzinga
- August 12·Benzinga
- July 8·Yahoo
- July 1·Yahoo
- July 1·Yahoo
- June 26·Yahoo
- June 24·Yahoo
- June 24·Yahoo
Trinity Biotech Stock Press Releases
Trinity Biotech regularly publishes news on the company's website that are relevant for investors.
- June 30•Trinity Biotech
- June 29•Trinity Biotech
- May 20•Trinity Biotech
- May 3•Trinity Biotech
- April 11•Trinity Biotech
- April 11•Trinity Biotech
- February 14•Trinity Biotech
- January 27•Trinity Biotech
- January 25•Trinity Biotech
- December 15•Trinity Biotech
- September 9•Trinity Biotech
- August 31•Trinity Biotech
- July 16•Trinity Biotech
- May 25•Trinity Biotech
- May 19•Trinity Biotech
- March 30•Trinity Biotech
- March 25•Trinity Biotech
- March 23•Trinity Biotech
- January 5•Trinity Biotech
- November 17•Trinity Biotech
- October 29•Trinity Biotech
- August 25•Trinity Biotech
- August 20•Trinity Biotech
- August 18•Trinity Biotech
- August 17•Trinity Biotech
- May 27•Trinity Biotech
- May 14•Trinity Biotech
- March 31•Trinity Biotech
- March 24•Trinity Biotech
Trinity Biotech News 2026
This page contains all current news, analysis and press releases for Trinity Biotech stock (TRIB, ISIN: US8964385046). This includes Eulerpool news, company analysis and official press releases. Data is updated regularly to provide investors with a complete overview of the latest developments at Trinity Biotech.
Trinity Biotech Stock
Trinity Biotech Trinity Biotech PLC is a healthcare company based in Bray, Ireland, with a focus on developing, manufacturing, and marketing medical diagnostic products. The company serves the clinical laboratory and point-of-care segments of the diagnostic market. Trinity Biotech employs 579 full-time staff and has been publicly traded since its IPO on October 21, 1992. Its products are designed to detect autoimmune, infectious, sexually transmitted diseases, diabetes, and disorders of the liver and intestine. The company operates through two geographic segments: the Americas and Rest of World. Product categories include point-of-care diagnostics, emergency medicine diagnostics, clinical laboratory reagents, and blood bank screening. The company's point-of-care brands are Uni-Gold and Recombigen, while its emergency medicine diagnostics cover acute care testing, STAT labs, pre/post-operative units, physician office labs, and central laboratories. Trinity Biotech supplies the clinical laboratory market with reagent products and other solutions through its clinical chemistry business. The blood bank screening division manufactures products to screen donated blood for transfusion-transmissible infections. The company's website is www.trinitybiotech.com. Trinity Biotech PLC is listed on the stock market under the ticker TRIB and ISIN US8964385046. The company's headquarters are located in Bray, Wicklow, Ireland.